Fernanda Valdez-Palomares

Ms. Fernanda Valdez-Palomares


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
FVFernanda Valdez-Palomares
Fernanda Valdez-Palomares
MTMarcela Muñoz Torrico
Marcela Muñoz Torrico
BPBerenice Palacios-Gonzalez
Berenice Palacios-Gonzalez
XSXavier Soberón
Xavier Soberón
ESEugenia Silva-Herzog
Eugenia Silva-Herzog
Mycobacterium tuberculosis infection has three discernible outcomes: active tuberculosis, latent tuberculosis, or clearance of the bacterium. The outcome of the infection depends on the interaction of the bacterium, the immune system, and the microbiome of the host. The current study uses 16S rRNA sequencing to determine the diversity and composition of the respiratory microbiome of drug-resistant and drug-sensitive tuberculosis patients as well as healthy volunteers. Tuberculosis patients exhibited increased microbial diversity and differentially abundant bacteria than healthy volunteers. Compositional differences were also observed when comparing drug-sensitive or -resistant tuberculosis patients. Finally, we defined and assessed the differences in the core sputum microbiota between tuberculosis patients and healthy volunteers. Our observations collectively suggest that in sputum, Mycobacterium tuberculosis infection is related to altered bacterial diversity and compositional differences of core members of the microbiome, with potential implications for the bacterial pulmonary ecosystem’s stability and function.

1 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
FVFernanda Valdez-Palomares
Fernanda Valdez-Palomares
TTTomas Texis
Tomas Texis
SSSergio Sánchez-García
Sergio Sánchez-García
JMJosé Darío Martinez-Ezquerro
José Darío Martinez-Ezquerro
PTPaola García de la Torre
Paola García de la Torre
VGVanessa Gonzalez-Covarrubias
Vanessa Gonzalez-Covarrubias
Hypertension is the leading cause for cardiovascular disease with over 60% prevalence in older adults, its control is complex and requires multidisciplinary approaches. The gut microbiome has shown relevant associations with hypertension development and progression, with some specific bacteria showing potential to explain and improve hypertension. Control of high blood pressure has not been directly associated with the gut microbiome and given its high interindividual variability this relationship is not fully clear. The aim of this study was to characterize the gut microbiome of older adults and to identify bacteria associated with hypertension control. Patients were 60 years and older from Mexico City and the metropolitan area, all were receiving antihypertensive treatment, and donated a feces sample during a routine medical visit. DNA was extracted from 240 samples using a commercial kit, the V3/V4 region of the 16S gene was sequenced and metataxonomic analyses were performed using QIIME and R. Bacterial abundance identified a core microbiome for hypertensive older adults with a decreased diversity with increasing age, but that did not differ for hypertension control. A differential analysis indicated that Escherichia-Shigella increased with age, and that Ruminococcus UCG-002, DTU 089 and several bacteria from the Lachnospiraceae family were distinctively abundant according to hypertension control, with statistical significance for diastolic blood pressure. Our results confirm and expand previous reports on the core gut microbiome of older adults suggesting a abundance changes in fiber fermenting bacteria of the Lachnospiraceae family in uncontrolled hypertension.